Nkarta, Inc. (NKTX)
2.80
+0.38
(+15.70%)
USD |
NASDAQ |
Apr 16, 16:00
2.80
0.00 (0.00%)
After-Hours: 17:36
Nkarta Shareholders Equity (Quarterly) : 312.32M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 22.70B |
| Allogene Therapeutics, Inc. | 292.54M |
| ImmunityBio, Inc. | -500.47M |
| Cullinan Therapeutics, Inc. | 408.73M |
| Zenas BioPharma, Inc. | 242.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 417.29M |
| Total Liabilities (Quarterly) | 104.97M |
| Debt to Equity Ratio | 0.2447 |
| Current Ratio | 12.69 |
| Net Debt Paydown Yield | 1.37% |